title: Treatment of hepatitis C virus/HIV coinfection.
abstract: Coinfection with HIV and hepatitis C virus (HCV) has grown in importance and clinical impact in recent years. This change is attributable to the increase in life expectancy of those living with HIV infection since the advent of highly active antiretroviral therapy. This article reviews treatment options for patients who are coinfected with HIV and HCV.
authors: Division of Digestive Diseases, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267-0595, USA.
authors: Sooyun
authors: S
authors: Chun
authors: Kenneth E
authors: KE
authors: Sherman
mesh_terms: D023241:Antiretroviral Therapy, Highly Active; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000150:complications*; D006526:Hepatitis C / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D007370:Interferon Type I / Q000009:adverse effects / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use*; D016312:Treatment Refusal
chemical_list: D000998:Antiviral Agents; D007370:Interferon Type I; D011994:Recombinant Proteins; D012254:Ribavirin